Cell Culture Technology– category –
-
Bio-Engine Launches New MSC Culture Media, Achieving 15.1-Hour Doubling Time and 2.8-Fold Exosome Yield Increase
BioEngine Sci-Tech Co, Ltd. China Overview Bio-Engine Sci-Tech Co, Ltd. announced the launch of two new Mesenchymal Stem Cell (MSC) culture medium products: the Omni-Expansion MSC Culture Kit and Exo MSC CD Exosome Expression Kit. Design... -
FUJIFILM Cellular Dynamics Opens iPSC Manufacturing Facility, Made Scientific & Pluristyx Announce iPSC Partnership Expansion
openPR.com USA Overview According to openPR.com, FUJIFILM Cellular Dynamics opened a new iPSC development and manufacturing facility in Madison in May 2026, significantly expanding its induced pluripotent stem cell production capacity. F... -
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
Continuous Chromatography & ICH Q13 Overcome Downstream Purification Challenges Amplified by Upstream Intensification
Separation Science Global Overview According to Separation Science, upstream bioreactor intensification, including N-1 perfusion seeding and high-density fed-batch, is creating new challenges for downstream purification. Continuous purif... -
MDPI Study Achieves mAb Yield Maximization and Cost Reduction Through Dynamic Simulation and Optimization of Fed-Batch Bioreactors
MDPI Global Overview A research paper published in MDPI demonstrates the effectiveness of dynamic simulation and optimization methods for fed-batch bioreactors in monoclonal antibody (mAb) production. Addressing the need for higher yield... -
MDPI Review Highlights Urgent Need for Cost-Effective, Sustainable Serum-Free Media to Enable Cultivated Meat Production
MDPI Global Overview A new MDPI review emphasizes that developing cost-effective and sustainable serum-free media is crucial for the commercial viability of cultivated meat and seafood, as media formulations currently account for 55–95% ... -
Kincell Bio Strengthens GMP Manufacturing for Autologous & Allogeneic Cell Therapies Across Diverse Modalities from US Two Sites
Kincell Bio USA Overview Kincell Bio announced enhanced GMP manufacturing services for both autologous and allogeneic cell therapy programs, leveraging two advanced facilities in Gainesville, Florida, and Research Triangle Park, North Ca... -
Green Elephant Biotech Highlights 74% Cost Reduction Potential and Accelerated Development in Cell & Gene Therapy Through Automation
Green Elephant Biotech Germany Overview Green Elephant Biotech has highlighted the potential of automation platforms to significantly reduce development timelines and manufacturing costs in cell and gene therapy (CGT). Cases like Multipl... -
Jordan Advances Global CAR-T Access with High-Efficiency Point-of-Care Manufacturing Using CliniMACS Prodigy
ASCO Publications Jordan Overview In a significant step towards democratizing advanced cell therapies, point-of-care manufacturing of anti-CD19.1 CAR-T cells using the Miltenyi CliniMACS Prodigy system was successfully demonstrated in Jo... -
Global Pharma and Biotech Firms Intensify Investment in Biologics Contract Manufacturing Market, openPR.com Reports
openPR.com USA Overview Global pharmaceutical and biotechnology companies are significantly increasing their investments in the biologics contract manufacturing (CDMO) market, as reported by openPR.com. FUJIFILM Diosynth Biotechnologies ...
